Literature DB >> 20879828

Inner ear drug delivery system from the clinical point of view.

Tatsunori Sakamoto1, Takayuki Nakagawa, Rie T Horie, Harukazu Hiraumi, Norio Yamamoto, Yayoi S Kikkawa, Juichi Ito.   

Abstract

CONCLUSION: Three types of inner ear drug delivery systems (DDS) that were ready to be applied in clinics were developed.
OBJECTIVES: To develop clinically applicable inner ear DDS for the treatment of inner ear disorders.
METHODS: Inner ear DDS using clinically applicable materials were developed and evaluated.
RESULTS: The systemic application of stealth-type nanoparticles encapsulating betamethasone provided superior therapeutic results for the treatment of noise-induced hearing loss compared with the systemic application of betamethasone in mice. Microparticles made of biodegradable polymer (poly (lactic/glycolic) acid, PLGA) encapsulating lidocaine were placed on the round window membrane of guinea pigs, and resulted in reasonable concentrations of lidocaine in the cochlea without serious adverse effects. The phase I/IIa clinical trial of the application of insulin-like growth factor-1 (IGF-1) in combination with gelatin hydrogel on the round window membrane was conducted, recruiting patients with acute sensorineural hearing loss after the failure of systemic application of steroids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20879828     DOI: 10.3109/00016489.2010.486801

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  5 in total

1.  A novel multipurpose modular mini-endoscope for otology.

Authors:  Alessandro Bozzato; Victoria Bozzato; Basel Al Kadah; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-16       Impact factor: 2.503

2.  Regeneration of Cochlear Hair Cells and Hearing Recovery through Hes1 Modulation with siRNA Nanoparticles in Adult Guinea Pigs.

Authors:  Xiaoping Du; Qunfeng Cai; Matthew B West; Ibrahima Youm; Xiangping Huang; Wei Li; Weihua Cheng; Don Nakmali; Donald L Ewert; Richard D Kopke
Journal:  Mol Ther       Date:  2018-03-10       Impact factor: 11.454

3.  Effect of transtympanic betamethasone delivery to the inner ear.

Authors:  Halil Erdem Özel; Fatih Özdoğan; Seren Gülşen Gürgen; Erkan Esen; Adin Selçuk; Selahattin Genç
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-29       Impact factor: 2.503

4.  Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs.

Authors:  Xiaoping Du; Kejian Chen; Satish Kuriyavar; Richard D Kopke; Brian P Grady; David H Bourne; Wei Li; Kenneth J Dormer
Journal:  Otol Neurotol       Date:  2013-01       Impact factor: 2.311

Review 5.  Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.

Authors:  Igor Khalin; Renad Alyautdin; Ganna Kocherga; Muhamad Abu Bakar
Journal:  Int J Nanomedicine       Date:  2015-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.